TRADENAME: TAGONIB
ACTIVE PRINCIPLE: Imatinib
PRESENTATIONS FOR SALE:
100 mg x 180 Comp. Rec.
400 mg x 30 Comp. Rec.
THERAPEUTIC ACTION: Antineoplastic agent.
Protein tyrosine kinase inhibitor.